Basis: FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.
The P/E ratio is N/A as of 2026-10-06T19:40:42.076Z.
Calculation as of: 2026-10-06T19:40:42.076Z.
Quote observation: 2026-10-06T19:40:10.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 6a2f90c369cc2bba861e7882df5fb589e6a534c6c6a3ec3aca589af2a274c9b5
PE RATIO
N/A
Anteris Technologies Global Corp.
Market Cap
$688.40M
PE Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | PE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Anteris Technologies Global Corp. (AVR) | $688.40M | N/A | N/A | N/A | N/A |
| Faeth Therapeutics, Inc. (FTH)vs › | $688.55M | N/A | N/A | N/A | N/A |
| Olema Pharmaceuticals, Inc. (OLMA)vs › | $686.42M | N/A | N/A | N/A | N/A |
| Verastem, Inc. (VSTM)vs › | $685.85M | N/A | N/A | N/A | N/A |
| Wave Life Sciences Ltd. (WVE)vs › | $691.64M | N/A | N/A | N/A | N/A |
| ArriVent BioPharma, Inc. (AVBP)vs › | $682.79M | N/A | N/A | N/A | N/A |
| Cytek Biosciences, Inc. (CTKB)vs › | $701.89M | N/A | 991.02 | 502.52 | 502.52 |
| Solid Biosciences Inc. (SLDB)vs › | $674.85M | N/A | N/A | N/A | N/A |
| MiMedx Group, Inc. (MDXG)vs › | $666.85M | 114.38 | 37.43 | 206.22 | 206.22 |
| Collegium Pharmaceutical, Inc. (COLL)vs › | $710.30M | 17.66 | 23.33 | 39.10 | 32.90 |
Trailing P/E
N/A
Forward P/E
N/A
Forward P/E is calculated using analyst consensus EPS estimates for the current or next fiscal year.
Calculation:
Current Price
$7.08
Forward EPS (Est.)
$-1.23
Forward P/E
N/A
Source: FMP Analyst Consensus Estimates. Forward EPS represents the average analyst estimate for the nearest fiscal year.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
